
What makes this call so interesting is that the company just announced earlier this week that its management will present in a fireside chat at the 2012 Deutsche Bank Access BioFEST Conference on December 3, 2012 in Boston. With a focus on hepatitis B and C it seems as though investors are hoping that the company’s pipeline in Phase II studies will have significant upside since Idenix has estimated that more than 170 million people worldwide are chronically infected with HCV.
Shares are up a sharp 13% at $5.13 on the news and the volume is already closing in on 1 million shares after only about an hour of trading. Idenix has a $685 million market cap and shares have a 52-week range of $3.35 to $15.25. Another observation is that the consensus analyst target is already about $7.20 here with a range of $4.00 to $15.00 for the stock.
JON C. OGG
The Average American Has No Idea How Much Money You Can Make Today (Sponsor)
The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.
But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.